Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer

Name: Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
License: Public Domain

Washington University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic biliary tract cancer, metastatic biliary tract carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 230414
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.